Market Research Logo

MediPoint: Point of Care Diagnostics - Global Analysis and Market Forecasts

MediPoint: Point of Care Diagnostics - Global Analysis and Market Forecasts

Summary

Point-of-care testing (POCT), as known as bedside/near-patient testing is one of the most rapidly growing areas in IVD. Systems that are categorized as POC include the following -

  • Disposable systems or devices, which vary from reagent test strips for a single analyte to multi-analyte reagent strips
  • Small analyzers, usually hand-held devices
  • Desktop analyzers are larger and include systems designed for use in clinics or small laboratories.
  • POCT may be performed in a variety of locations such as in secondary care including emergency departments, ambulance service, hospital wards, and intensive treatment units; and increasingly in the community and primary care including general practice (GP), health and community centers.
  • $2 billion in annual global sales and growth rate of 5.3% during the forecast period; the emerging markets: China, India and Brazil, are expected to show the fastest growth.
  • A number of factors, such as the increasing prevalence of infectious diseases in developing countries, the rising incidences of lifestyle diseases such as cardiac diseases and diabetes, the rising usage of home-based POC devices, expansion of test menu, and advancements in molecular testing and lab-on-chip technology are stimulating the demand for POC testing.
  • The rate of POC testing adoption will be moderated by the requirement for regulatory compliance, the pressure to control cost, and the need to demonstrate clear clinical-cost benefits of POC testing over central laboratory testing.
Highlights

Key Questions Answered
  • What is the current and future POC diagnostics market outlook in the developed and emerging markets? What trends are affecting the global market?
  • What is the competitive landscape and market share of major players in the POC space across different regions?
  • What are the key, high growth markets that IVD manufacturers should expand into? Which market segments are growing the fastest?
  • What are the unmet needs with the POC tests currently on the market? How will emerging technologies such as molecular POC assays fulfil these unmet needs?
  • What are the key factors influencing a physician to use POC tests? What is physician perception and market outlook of POC devices?
  • What are the challenges and barriers that have hindered widespread adoption of POC devices?
Scope
  • Competitive assessment: Currently marketed POC products and evolving competitive landscape
  • In-depth analysis of unmet needs and adoption trends of different POC devices
  • Insightful review of the key industry drivers, opportunities, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications
  • Pipeline analysis: Emerging products and technologies.
  • Annualized total POC diagnostics market revenue by segment and market outlooks by country from 2012-2021.
  • Other key topics covered include strategic competitive assessment, market characterization, identification of unmet needs, market dynamics, and implications of the emerging technologies on the market.
Reasons to buy
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline
  • Develop business strategies by understanding the trends shaping and driving the global market
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the performance of various competitors
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage
  • Track device sales in the global market from 2012-2021
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Catalyst
2.2 Related Reports
3 Industry Overview
3.1 POC Diagnostics Overview
3.2 Test Trends
3.2.1 Cardiac Markers POC Testing
3.2.2 Female Fertility and Pregnancy POC Testing
3.3 Mergers, Acquisitions, and Key Partnerships
4 Unmet Needs
4.1 Detection of Multiple Analytes
4.2 Sensitivity of Lateral Flow Technology
4.3 Analytical Quality
4.4 Markers for Myocardial Ischemia
4.5 Data Management
4.6 POC Diagnostics to Reduce Usage of Antibiotics
4.7 Cost-Effectiveness and Reimbursement
4.8 Gap between Physicians and Manufacturers
5 Market Drivers and Barriers
5.1 Drivers
5.1.1 Fast Turnaround Time
5.1.2 POC Molecular Testing Driving Infectious Disease POCT
5.1.3 Increasing Adoption of Cardiac Marker POCT
5.1.4 Expansion POC Testing Menu
5.1.5 Expansion of the Home-Testing Market
5.1.6 CLIA Waived Status for POCT
5.1.7 Rising Prevalence of Diseases
5.2 Barriers
5.2.1 Management of POCT
5.2.2 Competition with Laboratory Tests
5.2.3 Regulatory Compliance
5.2.4 Medical Device Excise Tax
6 Competitive Assessment
6.1 Company Share Analysis
6.1.1 Global
6.1.2 US
6.1.3 Europe
6.1.4 Asia-Pacific
6.2 Trends in Corporate Strategy
6.3 Major Players
6.3.1 Abbott Diagnostics
6.3.2 Akers Bioscience
6.3.3 Alere
6.3.4 Beckman Coulter
6.3.5 BioMerieux
6.3.6 Chembio Diagnostics
6.3.7 EKF Diagnostics
6.3.8 Meridian Bioscience
6.3.9 OraSure Technologies
6.3.10 Quidel
6.3.11 Radiometer Medical
6.3.12 Response Biomedical
6.3.13 Roche Diagnostics
6.3.14 Siemens Healthcare
6.3.15 Trinity Biotech
6.3.16 Other Companies
7 Pipeline Assessment
7.1 Overview
7.2 Pipeline Profiles
7.2.1 Cardiac Markers POCT
7.2.2 Female Fertility and Pregnancy POCT
7.2.3 Hematology POCT
7.2.4 Infectious Disease POCT
7.2.5 Immunochemistry POCT Analyzers
8 Market Outlook
8.1 By Market Segment
8.1.1 Global Overview
8.1.2 Cardiac Markers POCT
8.1.3 Female Fertility and Pregnancy POCT
8.1.4 Hematology POCT
8.1.5 Infectious Disease POCT
8.1.6 Immunochemistry POCT Analyzers
8.2 By Geography
8.2.1 Global Overview
8.2.2 US
8.2.3 France
8.2.4 Germany
8.2.5 Italy
8.2.6 Spain
8.2.7 UK
8.2.8 Japan
8.2.9 China
8.2.10 India
8.2.11 Brazil
9 Appendix
9.1 Bibliography
9.2 Abbreviations
9.3 Report Methodology
9.3.1 Overview
9.3.2 Coverage
9.3.3 Secondary Research
9.3.4 Forecasting Methodology
9.3.5 Primary Research — Key Opinion Leader Interviews
9.3.6 Primary Research - Physician and Industry Interviews
9.3.7 Expert Panel Validation
9.4 Physicians and Specialists Included in This Study
9.5 About the Authors
9.5.1 Analysts
9.5.2 Tyler Fletcher, Global Head of Medical Devices
9.6 About MediPoint
9.7 About GlobalData
9.8 Disclaimer
1.1 List of Tables
Table 1: Advantages and Disadvantages of POCT
Table 2: Global Troponin POCT Volume (thousands) Forecast by Country, 2012-2021
Table 3: Global B-type Natriuretic Peptide POCT Volume (thousands) Forecast by Country, 2012-2021
Table 4: Global Follicle-Stimulating Hormone POCT Volume Forecast by Country, 2012-2021
Table 5: Global Luteinizing Hormone POCT Volume (thousands) Forecast by Country, 2012-2021
Table 6: Global Human Chorionic Gonadotropin POCT Volume (thousands) Forecast by Country, 2012-2021
Table 7: Mergers, Acquisitions, and Key Partnerships, 2012-2016
Table 8: Company Profile - Abbott Diagnostics
Table 9: Abbott Diagnostics’ POC Portfolio Assessment, 2015
Table 10: SWOT Analysis - Abbott Diagnostics
Table 11: Company Profile - Akers Bioscience
Table 12: Aker Bioscience’s POC Portfolio Assessment, 2015
Table 13: SWOT Analysis - Akers Bioscience
Table 14: Company Profile - Alere
Table 15: Alere’s POC Portfolio Assessment, 2015
Table 16: SWOT Analysis - Alere
Table 17: Company Profile - Beckman Coulter
Table 18: Beckman Coulter’s POC Portfolio Assessment, 2015
Table 19: SWOT Analysis - Beckman Coulter
Table 20: Company Profile - BioMerieux
Table 21: BioMerieux’s POC Portfolio Assessment, 2015
Table 22: SWOT Analysis - BioMerieux
Table 23: Company Profile - Chembio Diagnostics
Table 24: Chembio Diagnostics’ POC Portfolio Assessment, 2015
Table 25: SWOT Analysis - Chembio Diagnostics
Table 26: Company Profile - EKF Diagnostics
Table 27: EKF Diagnostics’ POC Portfolio Assessment, 2015
Table 28: SWOT Analysis - EKF Diagnostics
Table 29: Company Profile - Meridian Bioscience
Table 30: Meridian Bioscience’s POC Portfolio Assessment, 2015
Table 31: SWOT Analysis - Meridian Bioscience
Table 32: Company Profile - OraSure Technologies
Table 33: OraSure Technologies’ POC Portfolio Assessment, 2015
Table 34: SWOT Analysis - OraSure Technologies
Table 35: Company Profile - Quidel
Table 36: Quidel’s POC Portfolio Assessment, 2015
Table 37: SWOT Analysis - Quidel
Table 38: Company Profile - Radiometer Medical
Table 39: Radiometer Medical’s POC Portfolio Assessment, 2015
Table 40: SWOT Analysis - Radiometer Medical
Table 41: Company Profile - Response Biomedical
Table 42: Response Biomedical’s POC Portfolio Assessment, 2015
Table 43: SWOT Analysis - Response Biomedical
Table 44: Company Profile - Roche Diagnostics
Table 45: Roche Diagnostics’ POC Portfolio Assessment, 2015
Table 46: SWOT Analysis - Roche Diagnostics
Table 47: Company Profile - Siemens Healthcare
Table 48: Siemens Healthcare’s POC Portfolio Assessment, 2015
Table 49: SWOT Analysis - Siemens Healthcare
Table 50: Company Profile - Trinity Biotech
Table 51: Trinity Biotech’s POC Portfolio Assessment, 2015
Table 52: SWOT Analysis - Trinity Biotech
Table 53: Other POC Companies in North America, 2015
Table 54: Other POC Companies in Europe, 2015
Table 55: Other POC Companies in APAC and Other Regions, 2015
Table 56: Key Cardiac Markers POCT Pipelines, 2015
Table 57: Key Female Fertility and Pregnancy POCT Pipelines, 2015
Table 58: Key Hematology POCT Pipelines, 2015
Table 59: Key Infectious Disease POCT Pipelines, 2015
Table 60: Key Immunochemistry POCT Analyzer Pipelines, 2015
Table 61: Global POC Diagnostics Sales Forecast ($m) by Market Segment, 2012-2021
Table 62: Cardiac Marker POCT Sales Forecast ($m), 2012-2021
Table 63: Fertility and Pregnancy POCT Sales Forecast ($m), 2012-2021
Table 64: Hematology POCT Sales Forecast ($m), 2012-2021
Table 65: Infectious Disease POCT Sales Forecast ($m), 2012-2021
Table 66: Immunochemistry POCT Analyzers Sales Forecast ($m), 2012-2021
Table 67: Global POC Diagnostics Sales Forecast ($m) by Country, 2012-2021
Table 68: US POC Diagnostics Sales Forecast ($m), 2012-2021
Table 69: France POC Diagnostics Sales Forecast ($m), 2012-2021
Table 70: Germany POC Diagnostics Sales Forecast ($m), 2012-2021
Table 71: Italy POC Diagnostics Sales Forecast ($m), 2012-2021
Table 72: Spain POC Diagnostics Sales Forecast ($m), 2012-2021
Table 73: UK POC Diagnostics Sales Forecast ($m), 2012-2021
Table 74: Japan POC Diagnostics Sales Forecast ($m), 2012-2021
Table 75: China POC Diagnostics Sales Forecast ($m), 2012-2021
Table 76: India POC Diagnostics Sales Forecast ($m), 2012-2021
Table 77: Brazil POC Diagnostics Sales Forecast ($m), 2012-2021
Table 78: POC Diagnostics - Primary Call Count by Country
1.2 List of Figures
Figure 1: Troponin POCT Volume by Country, 2012-2021
Figure 2: B-type Natriuretic Peptide POCT Volume by Country, 2012-2021
Figure 3: Follicle-Stimulating Hormone POCT Volume by Country, 2012-2021
Figure 4: Luteinizing Hormone POCT Volume by Country, 2012-2021
Figure 5: Human Chorionic Gonadotropin POCT Volume by Country, 2012-2021
Figure 6: Global POC Diagnostics Market, By Company Share, 2015
Figure 7: US POC Diagnostics Market, By Company Share, 2015
Figure 8: Europe POC Diagnostics Market, By Company Share, 2015
Figure 9: APAC POC Diagnostics Market, By Company Share, 2015
Figure 10: Global POC Diagnostics Sales Forecast ($m) by Market Segment, 2012-2021
Figure 11: Global POC Diagnostics Market Potential by Segment, 2021
Figure 12: Cardiac Marker POCT Sales Forecast ($m), 2012-2021
Figure 13: Fertility and Pregnancy POCT Sales Forecast ($m), 2012-2021
Figure 14: Hematology POCT Sales Forecast ($m), 2012-2021
Figure 15: Infectious Disease POCT Sales Forecast ($m), 2012-2021
Figure 16: Immunochemistry POCT Analyzers Sales Forecast ($m), 2012-2021
Figure 17: Global POC Diagnostics Sales Forecast ($m), 2012-2021
Figure 18: Global POC Diagnostics Market Share Forecast ($m) by Country, 2015 and 2021
Figure 19: Global POC Diagnostics Market Potential by Country, 2021
Figure 20: US POC Diagnostics Sales Forecast ($m), 2012-2021
Figure 21: US POC Diagnostics Market Revenue Breakdown, by Segment, 2015
Figure 22: France POC Diagnostics Sales Forecast ($m), 2012-2021
Figure 23: France POC Diagnostics Market Revenue Breakdown, by Segment, 2015
Figure 24: Germany POC Diagnostics Sales Forecast ($m), 2012-2021
Figure 25: Germany POC Diagnostics Market Revenue Breakdown, by Segment, 2015
Figure 26: Italy POC Diagnostics Sales Forecast ($m), 2012-2021
Figure 27: Italy POC Diagnostics Market Revenue Breakdown, by Segment, 2015
Figure 28: Spain POC Diagnostics Sales Forecast ($m), 2012-2021
Figure 29: Spain POC Diagnostics Market Revenue Breakdown, by Segment, 2015
Figure 30: UK POC Diagnostics Sales Forecast ($m), 2012-2021
Figure 31: UK POC Diagnostics Market Revenue Breakdown, by Segment, 2015
Figure 32: Japan POC Diagnostics Sales Forecast ($m), 2012-2021
Figure 33: Japan POC Diagnostics Market Revenue Breakdown, by Segment, 2015
Figure 34: China POC Diagnostics Sales Forecast ($m), 2012-2021
Figure 35: China POC Diagnostics Market Revenue Breakdown, by Segment, 2015
Figure 36: India POC Diagnostics Sales Forecast ($m), 2012-2021
Figure 37: India POC Diagnostics Market Revenue Breakdown, by Segment, 2015
Figure 38: Brazil POC Diagnostics Sales Forecast ($m), 2012-2021
Figure 39: Brazil POC Diagnostics Market Revenue Breakdown, by Segment, 2015
Figure 40: POC Diagnostics - Primary Call Count by Country (N=390)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report